144 related articles for article (PubMed ID: 31892573)
1. High Rate of Detection of Human ESPL1-HBV S Fusion Gene in Patients With HBV-related Liver Cancer: A Chinese Case-Control Study.
Hu B; Huang W; Wang R; Zang W; Su M; Li H; Wang H; Cao B; Deng D; Li QQ; Jiang J
Anticancer Res; 2020 Jan; 40(1):245-252. PubMed ID: 31892573
[TBL] [Abstract][Full Text] [Related]
2. Serum ESPL1 Can Be Used as a Biomarker for Patients With Hepatitis B Virus-Related Liver Cancer: A Chinese Case-Control Study.
Wang R; Zang W; Hu B; Deng D; Ling X; Zhou H; Su M; Jiang J
Technol Cancer Res Treat; 2020; 19():1533033820980785. PubMed ID: 33308056
[TBL] [Abstract][Full Text] [Related]
3. Correlation Between Serum ESPL1 and Hepatitis B Virus-related Hepatocellular Carcinoma Histological Grade: A Chinese Single-center Case-control Study.
Hu B; Wei LU; Liang H; Su M; Wang R; Su T; Li Q; Yin Q; Feng Y; Jiang J
Anticancer Res; 2023 Sep; 43(9):3997-4005. PubMed ID: 37648308
[TBL] [Abstract][Full Text] [Related]
4. Impact of AAV2 and Hepatitis B Virus Integration Into Genome on Development of Hepatocellular Carcinoma in Patients with Prior Hepatitis B Virus Infection.
Tatsuno K; Midorikawa Y; Takayama T; Yamamoto S; Nagae G; Moriyama M; Nakagawa H; Koike K; Moriya K; Aburatani H
Clin Cancer Res; 2019 Oct; 25(20):6217-6227. PubMed ID: 31320595
[TBL] [Abstract][Full Text] [Related]
5. [Identification of hepatitis B virus integration sites in hepatocellular carcinoma tissues from patients with chronic hepatitis B].
Tu H; Gao HF; Ma GH; Liu Y
Zhonghua Yi Xue Za Zhi; 2006 May; 86(18):1249-52. PubMed ID: 16796883
[TBL] [Abstract][Full Text] [Related]
6. A pilot systematic genomic comparison of recurrence risks of hepatitis B virus-associated hepatocellular carcinoma with low- and high-degree liver fibrosis.
Yoo S; Wang W; Wang Q; Fiel MI; Lee E; Hiotis SP; Zhu J
BMC Med; 2017 Dec; 15(1):214. PubMed ID: 29212479
[TBL] [Abstract][Full Text] [Related]
7. HBV DNA integrates into upregulated ZBTB20 in patients with hepatocellular carcinoma.
He Z; Zhu J; Mo J; Zhao H; Chen Q
Mol Med Rep; 2020 Jul; 22(1):380-386. PubMed ID: 32319639
[TBL] [Abstract][Full Text] [Related]
8. Association between polymorphisms of the
He XT; Xu HQ; Wang XM; He XS; Niu JQ; Gao PJ
World J Gastroenterol; 2017 Jan; 23(2):232-241. PubMed ID: 28127197
[TBL] [Abstract][Full Text] [Related]
9. Promoting effect of hepatitis B virus on the expressoin of phospholipase A2 group IIA.
Zhu C; Song H; Shen B; Wu L; Liu F; Liu X
Lipids Health Dis; 2017 Jan; 16(1):5. PubMed ID: 28077172
[TBL] [Abstract][Full Text] [Related]
10. Detection of Hepatitis B Virus-Host Junction Sequences in Urine of Infected Patients.
Lin SY; Su YP; Trauger ER; Song BP; Thompson EGC; Hoffman MC; Chang TT; Lin YJ; Kao YL; Cui Y; Hann HW; Park G; Shieh FS; Song W; Su YH
Hepatol Commun; 2021 Oct; 5(10):1649-1659. PubMed ID: 34558837
[TBL] [Abstract][Full Text] [Related]
11. Germline Duplication of SNORA18L5 Increases Risk for HBV-related Hepatocellular Carcinoma by Altering Localization of Ribosomal Proteins and Decreasing Levels of p53.
Cao P; Yang A; Wang R; Xia X; Zhai Y; Li Y; Yang F; Cui Y; Xie W; Liu Y; Liu T; Jia W; Jiang Z; Li Z; Han Y; Gao C; Song Q; Xie B; Zhang L; Zhang H; Zhang J; Shen X; Yuan Y; Yu F; Wang Y; Xu J; Ma Y; Mo Z; Yu W; He F; Zhou G
Gastroenterology; 2018 Aug; 155(2):542-556. PubMed ID: 29702115
[TBL] [Abstract][Full Text] [Related]
12. Impacts of human leukocyte antigen DQ genetic polymorphisms and their interactions with hepatitis B virus mutations on the risks of viral persistence, liver cirrhosis, and hepatocellular carcinoma.
Ji X; Zhang Q; Li B; Du Y; Yin J; Liu W; Zhang H; Cao G
Infect Genet Evol; 2014 Dec; 28():201-9. PubMed ID: 25281206
[TBL] [Abstract][Full Text] [Related]
13. Impact of hepatitis B virus (HBV) X gene integration in liver tissue on hepatocellular carcinoma development in serologically HBV-negative chronic hepatitis C patients.
Toyoda H; Kumada T; Kaneoka Y; Murakami Y
J Hepatol; 2008 Jan; 48(1):43-50. PubMed ID: 18023912
[TBL] [Abstract][Full Text] [Related]
14. Integration of tumour and viral genomic characterizations in HBV-related hepatocellular carcinomas.
Amaddeo G; Cao Q; Ladeiro Y; Imbeaud S; Nault JC; Jaoui D; Gaston Mathe Y; Laurent C; Laurent A; Bioulac-Sage P; Calderaro J; Zucman-Rossi J
Gut; 2015 May; 64(5):820-9. PubMed ID: 25021421
[TBL] [Abstract][Full Text] [Related]
15. PNPLA3 rs738409 is not associated with the risk of hepatocellular carcinoma and persistent infection of hepatitis B virus (HBV) in HBV-related subjects: A case-control study and meta-analysis on Asians.
Wang P; Wu C; Li Y; Gong Y; Shen N
Gene; 2020 Jun; 742():144585. PubMed ID: 32173542
[TBL] [Abstract][Full Text] [Related]
16. IL-17 and IL-21 polymorphisms in relation to HBV related hepatocellular carcinoma in Chinese Han population.
Wu W; Zeng Y; Lin J; Chen T; Xun Z; Li B; Wang C; Qin X; Qiu Y; Li Y; Chen M; Liang H; Li L; Shang H; Liu C; Ou Q
Infect Genet Evol; 2021 Jan; 87():104638. PubMed ID: 33232805
[TBL] [Abstract][Full Text] [Related]
17. Hepatitis B virus (HBV) DNA integration in patients with occult HBV infection and hepatocellular carcinoma.
Saitta C; Tripodi G; Barbera A; Bertuccio A; Smedile A; Ciancio A; Raffa G; Sangiovanni A; Navarra G; Raimondo G; Pollicino T
Liver Int; 2015 Oct; 35(10):2311-7. PubMed ID: 25677098
[TBL] [Abstract][Full Text] [Related]
18. Among Patients with Undetectable Hepatitis B Surface Antigen and Hepatocellular Carcinoma, a High Proportion Has Integration of HBV DNA into Hepatocyte DNA and No Cirrhosis.
Wong DK; Cheng SCY; Mak LL; To EW; Lo RC; Cheung TT; Seto WK; Fung J; Man K; Lai CL; Yuen MF
Clin Gastroenterol Hepatol; 2020 Feb; 18(2):449-456. PubMed ID: 31252193
[TBL] [Abstract][Full Text] [Related]
19. Increased ERp57 Expression in HBV-Related Hepatocellular Carcinoma: Possible Correlation and Prognosis.
Liu M; Du L; He Z; Yan L; Shi Y; Shang J; Tang H
Biomed Res Int; 2017; 2017():1252647. PubMed ID: 28373975
[No Abstract] [Full Text] [Related]
20. Viral integration drives multifocal HCC during the occult HBV infection.
Chen XP; Long X; Jia WL; Wu HJ; Zhao J; Liang HF; Laurence A; Zhu J; Dong D; Chen Y; Lin L; Xia YD; Li WY; Li GB; Zhao ZK; Wu K; Hou Y; Yu JJ; Xiao W; Wang GP; Zhu PC; Chen W; Bai MZ; Jian YX; Kristiansen K; Chen Q
J Exp Clin Cancer Res; 2019 Jun; 38(1):261. PubMed ID: 31200735
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
